miR-221 Exerts Antiviral and Anti-Inflammatory Effects against HSV-1 Through Direct Repression of CAMK2A and Immune Pathway Activation
Inflammation · 2026
DOI: 10.1007/s10753-025-02430-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, 2026. Verfasst von Jiahao Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, 213000, China. wjyyxujiahaoand@1…. Hauptthemen laut MEDLINE: MicroRNAs, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Herpesvirus 1, Human, Anti-Inflammatory Agents. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Technology Development Foundation of Jiangsu University, the Science and Technology Project (Social Development) of Wujin District.
Abstract (Originalsprache)
Herpes simplex virus type 1 (HSV-1) triggers significant inflammation and immune dysregulation, particularly in immunocompromised hosts. MicroRNA-221 (miR-221) is implicated in viral pathogenesis and inflammatory responses, yet its role in HSV-1 infection remains undefined. This study demonstrates that miR-221 suppresses HSV-1 replication, with 100 nM miR-221 reducing plaque formation by approximately 70% and markedly decreasing infectious viral titers (TCID50) in vitro. Mechanistically, bioinformatic analyses, dual-luciferase reporting, and RNA immunoprecipitation (RIP) confirmed CAMK2A, a calcium-signaling kinase, as a direct target of miR-221. KEGG pathway mapping linked miR-221 to calcium signaling, complement activation, and extracellular matrix interactions. In vivo, miR-221 overexpression in HSV-1-infected mouse corneas reduced pro-inflammatory cytokines (TNF-α, IL-6) and elevated anti-inflammatory IL-10, while enhancing CD8+ T-cell and NK-cell activation. Critically, it attenuated inflammatory cell infiltration and tissue apoptosis. CAMK2A inhibition synergistically amplified these antiviral and anti-inflammatory effects, whereas CAMK2A overexpression reversed them. We conclude that miR-221 restricts HSV-1 replication and modulates host inflammation by recruiting RISC to silence CAMK2A, thereby disrupting calcium signaling and promoting immune activation. These findings identify the miR-221/CAMK2A axis as a promising therapeutic target for HSV-1-induced inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, 213000, China. wjyyxujiahaoand@163.com.
- The Wujin Clinical College of Xuzhou Medical University, Changzhou, 213000, Jiangsu, P. R. China. wjyyxujiahaoand@163.com.
- Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, The Wujin Clinical College of Xuzhou Medical University, No.2, Yongning North Road, Tianning District, Changzhou,…
- Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, 213000, China.
- The Wujin Clinical College of Xuzhou Medical University, Changzhou, 213000, Jiangsu, P. R. China.
Förderung
- Clinical Technology Development Foundation of Jiangsu University
- the Science and Technology Project (Social Development) of Wujin District
Zitieren
APA
Xu, J., Xu, L., Hu, D., Zhang, Y., Wang, Y., & Yun, Z. (2026). miR-221 Exerts Antiviral and Anti-Inflammatory Effects against HSV-1 Through Direct Repression of CAMK2A and Immune Pathway Activation. Inflammation. https://doi.org/10.1007/s10753-025-02430-1
Vancouver
Xu J, Xu L, Hu D, Zhang Y, Wang Y, Yun Z. miR-221 Exerts Antiviral and Anti-Inflammatory Effects against HSV-1 Through Direct Repression of CAMK2A and Immune Pathway Activation. Inflammation. 2026. doi:10.1007/s10753-025-02430-1
BibTeX
@article{Xu2026,
author = {Xu, Jiahao and Xu, Lianhong and Hu, Die and Zhang, Ying and Wang, Yongfang and Yun, Zhihua},
title = {miR-221 Exerts Antiviral and Anti-Inflammatory Effects against HSV-1 Through Direct Repression of CAMK2A and Immune Pathway Activation},
journal = {Inflammation},
year = {2026},
doi = {10.1007/s10753-025-02430-1}
}
EUVIMED